Single cysteine to tyrosine transition inactivates the growth inhibitory function of Piedmontese myostatin.

Myostatin, a member of the transforming growth factor-beta superfamily, is a secreted growth factor that is proteolytically processed to give COOH-terminal mature myostatin and NH2-terminal latency-associated peptide in myoblasts. Piedmontese cattle are a heavy-muscled breed that express a mutated form of myostatin in which cysteine (313) is substituted with tyrosine. Here we have characterized the biology of this mutated Piedmontese myostatin. Northern and Western analyses indicate that there is increased expression of myostatin mRNA and precursor myostatin protein in the skeletal muscle of Piedmontese cattle. In contrast, a decrease in mature myostatin was observed in Piedmontese skeletal muscle. However, there is no detectable change in the circulatory levels of mature myostatin in Piedmontese cattle. Myoblast proliferation assay performed with normal and Piedmontese myostatin indicated that mature wild-type myostatin protein inhibited the proliferation of C2C12 myoblasts. Piedmontese myostatin, by contrast, failed to inhibit myoblast proliferation. In addition, when added in molar excess, Piedmontese myostatin acted as a potent "competitive inhibitor" molecule. These results indicate that, in Piedmontese myostatin, substitution of cysteine with tyrosine results in the distortion of the "cystine knot" structure and a loss of biological activity of the myostatin. This mutation also appears to affect either processing or stability of mature myostatin without altering the secretion of myostatin.

[1]  Se-Jin Lee,et al.  Regulation of myostatin activity and muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  U. Vitt,et al.  Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. , 2001, Molecular endocrinology.

[3]  F. Goetz,et al.  Differential skeletal muscle expression of myostatin across teleost species, and the isolation of multiple myostatin isoforms , 2001, FEBS letters.

[4]  B. Langley,et al.  Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation* , 2000, The Journal of Biological Chemistry.

[5]  K. Matthews,et al.  Myostatin, a transforming growth factor‐β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct , 1999, Journal of cellular physiology.

[6]  S. Arver,et al.  Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Gerrard,et al.  Myostatin expression in porcine tissues: tissue specificity and developmental and postnatal regulation. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[8]  T. P. Smith,et al.  Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. , 1997, Genome research.

[9]  L. Madisen,et al.  Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1: effects on secretion and bioactivity. , 1992, Molecular endocrinology.

[10]  D. Yaffe,et al.  Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle , 1977, Nature.

[11]  J. Massagué How cells read TGF-beta signals. , 2000, Nature reviews. Molecular cell biology.

[12]  Se-Jin Lee,et al.  The transforming growth factor β superfamily , 1996 .

[13]  G. Laurent,et al.  * Author for correspondence Summary , 2022 .